SDC2 and Sepsis: Combining our in vitro and in vivo models, our findings suggest that inflammation can ultimately lead to loss of cell viability in target organs, and the reduction of inflammatory cytokines is one of the possible protective mechanisms of CD362+ UC-MSCs in sepsis.